中文 | English
Return
Total: 107 , 1/11
Show Home Prev Next End page: GO
Author:(Yao-Zheng LING)

1.Role of Brg1 in regulating the Wnt/β-catenin signaling pathway in a bronchopulmonary dysplasia model.

Ling GUAN ; Mao-Zhu XU ; Yao-Zheng LING ; Li-Li YANG ; Ling-Huan ZHANG ; Sha LIU ; Wen-Jing ZOU ; Zhou FU

Chinese Journal of Contemporary Pediatrics 2025;27(6):731-739

2.Expert consensus on the diagnosis and treatment of cemental tear.

Ye LIANG ; Hongrui LIU ; Chengjia XIE ; Yang YU ; Jinlong SHAO ; Chunxu LV ; Wenyan KANG ; Fuhua YAN ; Yaping PAN ; Faming CHEN ; Yan XU ; Zuomin WANG ; Yao SUN ; Ang LI ; Lili CHEN ; Qingxian LUAN ; Chuanjiang ZHAO ; Zhengguo CAO ; Yi LIU ; Jiang SUN ; Zhongchen SONG ; Lei ZHAO ; Li LIN ; Peihui DING ; Weilian SUN ; Jun WANG ; Jiang LIN ; Guangxun ZHU ; Qi ZHANG ; Lijun LUO ; Jiayin DENG ; Yihuai PAN ; Jin ZHAO ; Aimei SONG ; Hongmei GUO ; Jin ZHANG ; Pingping CUI ; Song GE ; Rui ZHANG ; Xiuyun REN ; Shengbin HUANG ; Xi WEI ; Lihong QIU ; Jing DENG ; Keqing PAN ; Dandan MA ; Hongyu ZHAO ; Dong CHEN ; Liangjun ZHONG ; Gang DING ; Wu CHEN ; Quanchen XU ; Xiaoyu SUN ; Lingqian DU ; Ling LI ; Yijia WANG ; Xiaoyuan LI ; Qiang CHEN ; Hui WANG ; Zheng ZHANG ; Mengmeng LIU ; Chengfei ZHANG ; Xuedong ZHOU ; Shaohua GE

International Journal of Oral Science 2025;17(1):61-61

3.Research and application of thermosensitive Pickering emulsion with X-ray and ultrasound dual-modal imaging functions for intra-arterial embolization treatment.

Ling LI ; Anran GUO ; Haixia SUN ; Yanbing ZHAO ; Qing YAO ; Ling ZHANG ; Peng SHI ; Hongan TIAN ; Min ZHENG

Journal of Pharmaceutical Analysis 2025;15(4):101133-101133

4.Effect of circDNMT1 regulating miR-377-3p/PUM1 axis on proliferation,apoptosis and epithelial-mesenchymal transition of triple-negative breast cancer cells

Ming-Li LIN ; Mei-Ling ZHENG ; Hong-Quan LU ; Yao-Ting LIN

Journal of Regional Anatomy and Operative Surgery 2024;33(1):1-7

5.Construction and validation of a risk prediction model for postoperative delirium in primary liver cancer patients aged 60 years or older

Yao MA ; Ting LI ; Qiushi ZHANG ; Ling HU ; Jie ZHENG

Journal of Clinical Hepatology 2024;40(9):1816-1821

7.The use of melittin to enhance transgene expression mediated by recombinant adeno-associated virus serotype 2 vectors both in vitro and in vivo.

Yi-Lin XIE ; Ji-Yao WANG ; Yun HE ; Xiao-Min YU ; Qing-Yun ZHENG ; Chen LING ; Xi-Lin FENG ; Li-Qing ZHU

Journal of Integrative Medicine 2023;21(1):106-115

8.Antimicrobial susceptibility of Gram-positive organisms:Results from China antimicrobial resistance surveillance trial(CARST)program,2021-2022

Yun LI ; Bo ZHENG ; Feng XUE ; Xiu-Zhen ZHANG ; Yun-Jian HU ; Yu-Fen JIN ; Jian-Hong ZHAO ; Shi-Yang PAN ; Wei GUO ; Feng ZHAO ; Yun-Song YU ; Xuan CAI ; Wen-En LIU ; De-Hua LIU ; Ying FEI ; Jia-Yun LIU ; Feng-Yan PEI ; Ling MENG ; Ping JI ; Jin TANG ; Kai XU ; Lei ZHU ; Cun-Wei CAO ; He-Ping XU ; Shan WANG ; Lan-Qing CUI ; Jia ZHANG ; Yao-Yao LIU

The Chinese Journal of Clinical Pharmacology 2023;39(23):3509-3524

9.Antimicrobial susceptibility of Gram-negative organisms:Results from China antimicrobial resistance surveillance trial(CARST)program,2021-2022

Yun LI ; Bo ZHENG ; Feng XUE ; Xiu-Zhen ZHANG ; Yun-Jian HU ; Yu-Fen JIN ; Jian-Hong ZHAO ; Shi-Yang PAN ; Wei GUO ; Feng ZHAO ; Yun-Song YU ; Xuan CAI ; Wen-En LIU ; De-Hua LIU ; Ying FEI ; Jia-Yun LIU ; Feng-Yan PEI ; Ling MENG ; Ping JI ; Jin TANG ; Kai XU ; Lei ZHU ; Cun-Wei CAO ; He-Ping XU ; Shan WANG ; Lan-Qing CUI ; Jia ZHANG ; Yao-Yao LIU

The Chinese Journal of Clinical Pharmacology 2023;39(23):3525-3544

10.Incidence and related factors of antiviral drug resistance in HIV-infected pregnant and postpartum women in some areas of three western provinces of China from 2017 to 2019.

He SUN ; Ai Ling WANG ; Jun YAO ; Jia Rui ZHENG ; Qing Hua QIN ; Wu Li SHA ; Xiao Yan WANG ; Ya GAO ; Zhen LI ; Dong Xu HUANG ; Qian WANG

Chinese Journal of Preventive Medicine 2023;57(11):1788-1793

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 107 , 1/11 Show Home Prev Next End page: GO